EC approval for Rebif use extension for early MS

A board to discuss the Multiple Sclerosis modifying drug Rebif

EC approval for Rebif use extension for early MS

Postby MSUK » Wed Jan 25, 2012 3:09 am

Image

Merck KGaA said the European Commission or EC has approved extension of the indication of Rebif, a treatment for relapsing forms of multiple sclerosis or MS. This EC approval, based on REFLEX study results, is for the use of Rebif 44 micrograms three times weekly in patients who have experienced a single demyelinating event, an early sign of the disease, and who are at high risk of converting to MS....Read More http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1901
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to Rebif

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service